BBC3 and ovarian carcinoma: Because ROS generation may be caused by caspase activation [33], we treated ovarian cancer cells with Ad-PUMA plus Z-VAD-FMK, and found that ROS did not significantly decreased (Figure 3A and 3B), thus ruling out the possibility that PUMA-induced ROS generation is a consequence of caspase activation.